Search results
Higher NSAID Dose Raises CVD Risk in Ankylosing Spondylitis
Medscape· 16 hours agoNSAIDs, the primary pain management therapy for AS, increased the risk for vascular events and...
Stem cell treatments in Mexico linked to drug-resistant meningitis, joint infections
United Press International via Yahoo News· 1 day agoAntibiotic-resistant meningitis or severe, long-lasting joint infections: That's what three U.S....
Citizens Business Bank Sells 329 Shares of Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 5 days agoCitizens Business Bank lowered its holdings in Johnson & Johnson (NYSE:JNJ – Free Report) by 8.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities ...
Johnson & Johnson (NYSE:JNJ) Shares Sold by Wealthcare Advisory Partners LLC
ETF DAILY NEWS· 8 hours agoWealthcare Advisory Partners LLC reduced its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 3.4% in the 4th quarter, according to the company in its most recent filing with the Securities ...
Kim Kardashian’s Met Gala Look Had 1 Detail So Extreme It Made People Uncomfortable
The Huffington Post· 3 days agoThe reality TV star wore a custom Maison Margiela Artisanal gown by John Galliano with a metal...
Q2 2024 EPS Estimates for Amgen Inc. Reduced by Leerink Partnrs (NASDAQ:AMGN)
ETF DAILY NEWS· 4 days agoAmgen Inc. (NASDAQ:AMGN – Free Report) – Stock analysts at Leerink Partnrs reduced their Q2 2024 earnings estimates for Amgen in a research report issued on Friday, May 3rd. Leerink Partnrs ...
Q3 2024 EPS Estimates for Johnson & Johnson (NYSE:JNJ) Cut by Analyst
ETF DAILY NEWS· 9 hours agoJohnson & Johnson (NYSE:JNJ – Free Report) – Investment analysts at Zacks Research lowered their Q3 2024 earnings estimates for shares of Johnson & Johnson in a research note issued on Tuesday ...
Spire Wealth Management Sells 5,652 Shares of Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 10 hours agoSpire Wealth Management lowered its stake in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 13.6% during the fourth quarter, HoldingsChannel reports. The firm owned 35,894 shares of ...
Analysts Set Ventyx Biosciences, Inc. (NASDAQ:VTYX) PT at $21.75
ETF DAILY NEWS· 2 days agoVentyx Biosciences, Inc. (NASDAQ:VTYX – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the nine research firms that are currently covering the company, MarketBeat ...